Market Insights Health Pharmacies OTC Products

Digestive & Intestinal Remedies (Pharmacies) - China

China

Revenue in the Digestives & Intestinal Remedies market is projected to reach €3.12bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.37%, resulting in a market volume of €3.34bn by 2029.
In global comparison, most revenue will be generated in China (€3,122.00m in 2024).
In relation to total population figures, per person revenues of €2.18 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in China is experiencing significant growth and development.

Customer preferences: Chinese consumers are increasingly seeking digestive and intestinal remedies to address common health issues such as indigestion, bloating, and acid reflux. This is driven by several factors, including changing dietary habits, increased stress levels, and a growing awareness of the importance of gut health. As a result, there is a rising demand for over-the-counter remedies that can provide quick relief and improve overall digestive well-being.

Trends in the market: One key trend in the Digestive & Intestinal Remedies market in China is the growing popularity of traditional Chinese medicine (TCM) remedies. Chinese consumers have a long-standing trust in TCM and its holistic approach to healthcare. Many TCM remedies, such as herbal teas and herbal supplements, are believed to have digestive benefits and are widely used for digestive health maintenance. This trend is driving the demand for TCM-based digestive remedies in pharmacies across China. Another trend in the market is the increasing availability and variety of probiotic products. Probiotics are live bacteria and yeasts that are beneficial for gut health. They are commonly found in fermented foods and supplements. Chinese consumers are becoming more aware of the benefits of probiotics and are actively seeking products that can improve their gut microbiome. Pharmacies in China are responding to this demand by offering a wide range of probiotic products, including capsules, powders, and yogurts.

Local special circumstances: China has a large aging population, which is prone to digestive problems such as constipation and gastrointestinal disorders. This demographic trend is driving the demand for digestive remedies in pharmacies. Additionally, the fast-paced lifestyle in urban areas of China often leads to irregular eating habits and high-stress levels, which can contribute to digestive issues. As a result, pharmacies are strategically located in convenient locations to cater to the needs of busy urban consumers.

Underlying macroeconomic factors: China's growing middle class and increasing disposable income are driving the demand for healthcare products, including digestive remedies. As consumers become more health-conscious, they are willing to spend more on products that can improve their overall well-being. The Chinese government's focus on healthcare reforms and the promotion of traditional Chinese medicine have also contributed to the growth of the Digestive & Intestinal Remedies market in China. Furthermore, the expanding e-commerce sector in China has made it easier for consumers to access a wide range of digestive remedies online, further boosting market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in China is witnessing significant growth due to changing consumer preferences, the popularity of traditional Chinese medicine, and the increasing availability of probiotic products. The local special circumstances, such as the aging population and fast-paced lifestyle, further contribute to the market's development. The underlying macroeconomic factors, including the growing middle class and government support for healthcare reforms, also play a crucial role in driving market growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.